AbCellera Biologics Inc. ABCL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $102.06M-20.6% | $128.51M+18.8% | $108.16M-7.9% | $117.44M-36.3% | $184.27M+17.9% | ||
| $39.16M-0.6% | $39.41M-44.7% | $71.25M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $664.6M-8.7% | $728.23M+4.8% | $695.14M-6.3% | $742.15M-3.0% | $764.98M+1.8% | ||
| $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | ||
| $17.21M-55.2% | $38.38M+114% | $17.91M-1.9% | $18.26M-1.9% | $18.61M-55.8% | ||
| $642.52M+2.2% | $628.72M-4.9% | $660.85M+0.1% | $659.92M+13.9% | $579.23M-4.9% | ||
| $1.31B-3.7% | $1.36B+0.1% | $1.36B-3.3% | $1.4B+4.3% | $1.34B-1.2% | ||
| $20.81M-17.5% | $25.23M-20.6% | $31.77M-0.8% | $32.04M-2.3% | $32.8M-4.5% | ||
| $7.74M-42.8% | $13.53M-13.8% | $15.69M-7.4% | $16.95M-9.8% | $18.79M+38.9% | ||
| $47.29M-26.5% | $64.31M-6.5% | $68.8M+2.7% | $67.02M-11.1% | $75.4M-1.6% | ||
| $321.74M-1.2% | $325.74M+0.8% | $323.15M-1.5% | $327.96M+33.4% | $245.83M+7.9% | ||
| $369.03M-5.4% | $390.05M-0.5% | $391.95M-0.8% | $394.99M+23.0% | $321.23M+5.5% | ||
| $816.53M+1.8% | $802.34M+1.0% | $794.47M+0.4% | $791.67M+0.2% | $790.07M+1.7% | ||
| -$72.65M-146% | -$29.48M-43.6% | -$20.54M-156% | $36.58M-48.7% | $71.31M-39.0% | ||
| $938.08M-3.0% | $966.9M+0.3% | $964.04M-4.3% | $1.01B-1.6% | $1.02B-3.1% | ||
| $1.31B-3.7% | $1.36B+0.1% | $1.36B-3.3% | $1.4B+4.3% | $1.34B-1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can AbCellera Biologics Inc. cover its short-term obligations?
- Its current ratio is 14.05 — current assets exceed current liabilities.
- Where does AbCellera Biologics Inc.'s balance sheet data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.